Evaluation of Duloxetine and Innovative Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence — DULOXING

Stress Urinary Incontinence in Women Clinical Trial

Official title:
A Randomized-Intervention, Parallel, Multicentric Study to Evaluate Duloxetine and Innovative Pelvic Floor Muscle Training in Women With Uncomplicated Stress Urinary Incontinence - The DULOXING Study

Status Completed

Clinical Trial Summary

This study will evaluate the safety, tolerability and efficacy of duloxetine and pelvic floor muscle training in women who suffer from stress urinary incontinence

Clinical Trial Description

This is a randomized-intervention, parallel, multicentric study which will evaluate the safety, tolerability and efficacy of oral duloxetine and innovative pelvic floor muscle training to woman suffering from stress urinary incontinence ;

Study Design

Related Conditions & MeSH terms

Enuresis
Stress Urinary Incontinence in Women
Urinary Incontinence
Urinary Incontinence, Stress

Clinical Trial Details

NCT number	NCT04140253
Study type	Interventional
Source	Comenius University
Contact
Status	Completed
Phase	N/A
Start date	February 1, 2019
Completion date	March 10, 2020

View Details

See also
	Status	Clinical Trial	Phase
	Unknown status	`NCT00541151` - MiniArc Study: Long-Term Effectiveness Trial for AMS Sling Systems	Phase 4
	Completed	`NCT05053373` - Evaluation of Integrated Optimization Schemes for Female Stress Incontinence	N/A